Bank of America
NPCE icon

Bank of America’s Neuropace NPCE Stock Holding History

Bank of America’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$325K Sell
24,698
-145,741
-86% -$2.19M ﹤0.01% 5122
2025
Q4 		$2.63M Buy
170,439
+112,762
+196% +$1.51M ﹤0.01% 3854
2025
Q3 		$595K Buy
57,677
+11,124
+24% +$105K ﹤0.01% 5675
2025
Q2 		$519K Sell
46,553
-84,622
-65% -$1.06M ﹤0.01% 5685
2025
Q1 		$1.61M Buy
131,175
+106,727
+437% +$1.34M ﹤0.01% 4856
2024
Q4 		$274K Buy
24,448
+11,088
+83% +$96.4K ﹤0.01% 5948
2024
Q3 		$93.1K Sell
13,360
-3,958
-23% -$28.9K ﹤0.01% 6350
2024
Q2 		$131K Buy
17,318
+3,612
+26% +$36.4K ﹤0.01% 6115
2024
Q1 		$181K Sell
13,706
-18,199
-57% -$260K ﹤0.01% 5931
2023
Q4 		$329K Buy
31,905
+26,405
+480% +$211K ﹤0.01% 5778
2023
Q3 		$53.5K Hold
5,500
– – ﹤0.01% 6484
2023
Q2 		$24.7K Sell
5,500
-7,516
-58% -$34K ﹤0.01% 6661
2023
Q1 		$60.4K Hold
13,016
– – ﹤0.01% 6439
2022
Q4 		$19.4K Buy
13,016
+11,210
+621% +$24.9K ﹤0.01% 6745
2022
Q3 		$7K Sell
1,806
-1,370
-43% -$6.6K ﹤0.01% 7310
2022
Q2 		$16K Sell
3,176
-1,403
-31% -$9.27K ﹤0.01% 7249
2022
Q1 		$38K Sell
4,579
-2,299
-33% -$19.8K ﹤0.01% 7291
2021
Q4 		$69K Buy
6,878
+3,966
+136% +$51.5K ﹤0.01% 7063
2021
Q3 		$46K Buy
2,912
+875
+43% +$18.4K ﹤0.01% 7089
2021
Q2 		$48K Buy
+2,037
New +$47.3K ﹤0.01% 6852

Other funds holding NPCE

PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Bank of America's NPCE Position: Q1 2026 in Review

Bank of America reduced its Neuropace (NPCE) stake by 86% in Q1 2026, selling an estimated $2.19M and leaving 24,698 shares worth $325K. The position accounts for ﹤0.01% of the portfolio, ranked #5122.

Bank of America first reported a position in NPCE in Q2 2021 and has held it in 20 quarters since. The position peaked at $2.63M in Q4 2025. 113 funds tracked by Wall St. Rank hold NPCE as of Q1 2026.

  • Bank of America held 24,698 shares of Neuropace worth $325K as of Q1 2026.
  • Bank of America sold 145,741 Neuropace shares in Q1 2026, an estimated $2.19M.
  • Neuropace made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5122 holding.
  • Bank of America first reported a position in Neuropace in Q2 2021 and has held it in 20 quarters since.
  • Bank of America's Neuropace position peaked at $2.63M in Q4 2025.
  • 113 funds tracked by Wall St. Rank held Neuropace as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.